Vitamin price-fixing litigation
This article was originally published in The Tan Sheet
Executive Summary
Sumitomo Chemical Co. dismissed from vitamin price-fixing class action due to lack of personal jurisdiction. In an April 24 opinion, D.C. federal Judge Thomas Hogan concludes Japan-based firm "lacks the requisite local contacts to support personal jurisdiction" in the district. Sumitomo was among the nonsettling defendants named in a class action, certified in February, on behalf of direct purchasers of vitamins A, B, C, E, beta carotene and premixes (1"The Tan Sheet" March 4, 2002, p. 11)...
You may also be interested in...
Vitamin price-fixing
Dietary supplement manufacturer and multi-level marketer Shaklee is one of eight representative plaintiffs in class action suit certified by D.C. federal Judge Thomas Hogan Feb. 25. Action was filed in June 2000 on behalf of direct purchasers of vitamins A, B, C, E, beta carotene and premixes from nonsettling defendants "or their co-conspirators" between Jan. 1, 1990 and Sept. 30, 1998. Defendants include Merck KgaA, Sumitomo Chemical America, Tanabe USA, Lonza, Nepera, Reilly Industries, Degussa-Huls. The thousands of class members will be given chance to opt out; 224 class members, representing approximately 75% of vitamin purchases at issue, previously opted out of a class settlement against seven defendants, including Hoffman-LaRoche, BASF (1"The Tan Sheet" April 3, 2000, p. 7)...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.